New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
›ETF Issuers›L&G›BIGT
BIGT

L&G Pharma Breakthrough UCITS ETF

Passive ETFEquityESGTheme: Tomorrow's Treatments

The BIGT Exchange Traded Fund (ETF) is provided by L&G. It is built to track an index: Solactive Pharma Breakthrough Value Index. The BIGT ETF provides physical exposure, so by buying it you actually own parts of all the 36 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

Diversification
Data as of 05/31/26
No. of holdings
36
Effective diversification
35.3
Total weight of top 15 holdings
46.54%
Top 15 Holdings
Data as of 05/31/26
Travere Therapeutics, Inc.
4.28%
Jazz Pharmaceuticals Plc
3.47%
Pharma Mar SA
3.31%
United Therapeutics Corp.
3.18%
Royalty Pharma Plc
3.12%
Ligand Pharmaceuticals, Inc.
3.07%
Swedish Orphan Biovitrum AB
3.03%
Zevra Therapeutics, Inc.
3.02%
Mirum Pharmaceuticals, Inc.
3.01%
argenx SE
2.97%
Ultragenyx Pharmaceutical, Inc.
2.86%
Xeris Biopharma Holdings, Inc.
2.83%
PTC Therapeutics, Inc.
2.83%
LG Chem Ltd.
2.77%
Kyowa Kirin Co., Ltd.
2.77%
Sector exposures
Data as of 05/31/26
Healthcare
Industrials
020%40%60%80%100%
Country exposures
Data as of 05/31/26
USA
Japan
Switzerland
Netherlands
Ireland
Spain
Sweden
Republic of Korea
France
Denmark
Other
020%40%60%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
ETF TOOLS
ETF ScreenerCompare ETFsCompare ETF issuersWatchlistsETF Portfolio InsightsIndustry dataETF stock exposure finder
PLATFORM
Support and feedback
ETF NEWS & RESEARCH
Latest ETF NewsETF Research ReportsGlobal ETF Survey 2025Learn ETF investing
PROFESSIONAL SOLUTIONS
Enterprise SolutionsDue Diligence ServicesETF Data Services
SOLUTIONS FOR
Institutional investorsPrivate banksFinancial advisorsFintech and mediaIndividual investors
CONTACT US
General inquiries
Press and media
Advertising opportunities
Support and feedback
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Get our newsletters
Trackinsight